| 前收盘价格 | 0.310 |
| 收盘价格 | 0.310 |
| 成交量 | 201,682 |
| 平均成交量 (3个月) | 483,943 |
| 市值 | 7,725,770 |
| 价格/销量 (P/S) | 16.04 |
| 股市价格/股市净资产 (P/B) | 39.30 |
| 52周波幅 | |
| 利润日期 | 28 Jul 2025 - 1 Aug 2025 |
| 营业毛利率 | -269.86% |
| 营业利益率 (TTM) | -190.43% |
| 稀释每股收益 (EPS TTM) | -0.010 |
| 季度收入增长率 (YOY) | 27.20% |
| 流动比率 (MRQ) | 1.80 |
| 营业现金流 (OCF TTM) | -7.79 M |
| 杠杆自由现金流 (LFCF TTM) | -4.72 M |
| 资产报酬率 (ROA TTM) | -114.82% |
| 股东权益报酬率 (ROE TTM) | -457.46% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Health Information Services (AU) | 混合的 | 混合的 |
| Health Information Services (全球的) | 看跌 | 混合的 | |
| 股票 | PAINCHEK FPO [PCK] | - | - |
AIStockmoo 评分
-1.3
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | -2.5 |
| 技术振荡指标 | -0.5 |
| 平均 | -1.25 |
|
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications that provide pain assessment for individuals who are unable to communicate pain with carers. It operates in one segment, namely the sale of its pain assessment solutions. Its geographic segments include Australia, the United Kingdom, and Other countries, of which it generates the majority of its revenue from Australia. |
|
| 部门 | Healthcare |
| 行业 | Health Information Services |
| 投资方式 | Small Growth |
| 内部持股比例 | 34.46% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合